“Completely unnecessary.” That’s Jensen Huang’s read on Anthropic’s push for an AI safety antitrust waiver, and as someone who spends most of his week writing verdicts on other people’s work, I have to respect the economy of it. Two words. No hedging. Most product reviews should be that decisive.
I also have to admit I can’t fully evaluate it, and neither can you. What’s confirmed is narrow: in 2026, Huang publicly criticized Anthropic’s safety proposal, the criticism got picked up everywhere, and the specifics of what he objected to haven’t been laid out in detail. That’s the whole verified pile. Anyone writing 2,000 words on the clause-by-clause merits right now is filling in the blanks with vibes.
So let’s do something more useful than pretending otherwise. Let’s talk about why this fight matters to the people who actually assemble AI toolkits for a living, and what I’d need to see before I’d side with either party.
What an antitrust waiver actually asks for
In broad terms, a safety-focused antitrust waiver is a request for permission to talk. Competing labs coordinating on anything — release timing, capability thresholds, what they’ll refuse to ship — starts to look like collusion under normal competition law. A waiver carves out a lane where that conversation is legal.
I want to be clear that I have not read Anthropic’s proposal text, and I’m not going to characterize its provisions. But the general shape of these requests explains why they get contentious fast. The same mechanism that lets rivals agree on a shared safety floor also lets them agree on a shared ceiling, and the difference between the two comes down to drafting.
Why a toolkit reviewer cares
My job is comparing things. I run the same prompts across models, log where they break, and try to tell you whether the tool survives contact with real work. Coordination between labs shows up in that job in ways most coverage skips.
- Documentation becomes comparable. Right now every lab reports evals its own way, which makes honest side-by-side testing a slog. Agreed standards would fix that faster than any amount of me complaining in reviews.
- Refusal behavior gets predictable. Builders currently ship per-vendor workarounds because each model draws its lines somewhere different. Shared norms would cut that maintenance tax.
- Or the floor becomes a wall. If a coordinated standard arrives with compliance overhead that only companies with legal departments can absorb, the small shops and open-weight projects I review get squeezed out. That’s the version I’d fight.
Both outcomes come from the same door. Which is why “completely unnecessary” isn’t obviously wrong, and isn’t obviously right either.
Read the incentives, not the adjectives
Everybody in this argument has a position, and the positions are not hidden.
Nvidia sells the compute. A market with many buyers racing hard is a better market for Nvidia than one where a handful of large labs coordinate on pacing. Any structure that lets big players set shared rules is a structure that could, eventually, shape how much silicon gets bought and when.
Anthropic sells safety as a differentiator. Its whole market identity is built on being the careful one. A legal framework that rewards caution industry-wide converts that identity from a marketing line into a compliance baseline that competitors have to meet.
Neither of those is a scandal. It’s just why the loudest voices in the room are the ones with the most to gain from the answer. Nobody here is a disinterested referee, including the reporters covering it.
What I’d want on the table
If I were reviewing this the way I’d review a dev tool, my open questions would be:
- Who gets a seat? If the coordination table is invite-only for labs above a certain size, that’s a moat with a safety label on it.
- Is there a sunset clause? Temporary exemptions that get renewed forever have a poor track record across every industry that’s tried them.
- What’s explicitly out of scope? Pricing, capacity, release timing. If those aren’t fenced off in writing, the objection writes itself.
- Does it produce artifacts I can check? Shared eval formats and published methodology would be a real win for anyone doing independent testing.
Should you change anything today
No. Nothing in your stack breaks because two executives disagree about competition law. Keep shipping.
What I’d actually watch is whether Anthropic publishes the full proposal and whether Huang expands past two words. A policy fight where one side has a document and the other has a soundbite tends to resolve in favor of the document, but a soundbite from the company supplying most of the industry’s compute carries weight that no white paper matches.
My verdict is incomplete, and I’d rather say that than fake a score. Come back when there’s something to read.
đź•’ Published: